Andreas Fibig - Bunge Director

BG Stock  USD 103.26  0.84  0.82%   

Director

Mr. Andreas Fibig is no longer Independent Director of the Company effective May 2018. He is Chairman and CEO of International Flavors Fragrances Inc., a leading global innovator of flavors, fragrances and cosmetic active ingredients for consumer products. Previously, he was President and Chairman of the Board of Management of Bayer HealthCare Pharmaceuticals, the pharmaceutical division of Bayer AG, and held senior leadership roles at Pfizer Inc. and Pharmacia. Mr. Fibig holds a degree in Marketing and Business Management from Berlins University of Economics. He chairs the Board of Trustees of the Max Planck Institute for Infection Biology since 2016.
Age 55
Tenure 8 years
Address 1391 Timberlake Manor Parkway, Chesterfield, MO, United States, 63017
Phone314 292 2000
Webhttps://www.bunge.com
Fibig’s experience leading a global publicly traded company serving the consumer products industry, and in particular developing innovative solutions for food and beverage companies, provides him with valuable insights on consumer preferences and tastes as we continue to grow our Food & Ingredients business. Additionally, he brings to our Board strategic, operational, management, marketing and regulatory expertise.

Bunge Management Efficiency

The company has Return on Asset (ROA) of 0.0819 % which means that for every $100 of assets, it generated a profit of $0.0819. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.2147 %, which means that it produced $0.2147 on every 100 dollars invested by current stockholders. Bunge's management efficiency ratios could be used to measure how well Bunge manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bunge's Return On Assets are most likely to increase slightly in the upcoming years. The Bunge's current Return On Equity is estimated to increase to 0.22, while Return On Capital Employed is projected to decrease to 0.07. At this time, Bunge's Deferred Long Term Asset Charges is most likely to decrease significantly in the upcoming years. The Bunge's current Return On Assets is estimated to increase to 0.09, while Other Assets are projected to decrease to roughly 1.1 B.
The company reports 5.76 B of total liabilities with total debt to equity ratio (D/E) of 0.65, which is normal for its line of buisiness. Bunge Limited has a current ratio of 1.6, which is generally considered normal. Debt can assist Bunge until it has trouble settling it off, either with new capital or with free cash flow. So, Bunge's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bunge Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bunge to invest in growth at high rates of return. When we think about Bunge's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Lisa HookPhilip Morris International
63
Hala ModdelmogLamb Weston Holdings
64
Gerald BalilesAltria Group
75
Lewis BoothMondelez International
69
Harold BrownPhilip Morris International
90
Barre SeibertTootsie Roll Industries
79
Dessislava TemperleyPhilip Morris International
48
Stephanie BurnsKellanova
66
Charles BunchMondelez International
68
Marcella KainKellanova
N/A
Jennifer LiPhilip Morris International
52
James JennessKellanova
73
Thomas MaurerLamb Weston Holdings
69
Mary LaschingerKellanova
60
Werner GeisslerPhilip Morris International
67
Gordon GundKellanova
74
Rebecca BousteadKellanova
N/A
Peter MayMondelez International
75
Maria SharpeLamb Weston Holdings
62
Patrick SiewertMondelez International
62
Stephen BollenbachMondelez International
72
Bunge Limited operates as an agribusiness and food company worldwide. Bunge Limited was founded in 1818 and is headquartered in St. Bunge operates under Farm Products classification in the United States and is traded on New York Stock Exchange. It employs 23000 people. Bunge Limited (BG) is traded on New York Stock Exchange in USA. It is located in 1391 Timberlake Manor Parkway, Chesterfield, MO, United States, 63017 and employs 23,000 people. Bunge is listed under Agricultural Products & Services category by Fama And French industry classification.

Management Performance

Bunge Limited Leadership Team

Elected by the shareholders, the Bunge's board of directors comprises two types of representatives: Bunge inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bunge. The board's role is to monitor Bunge's management team and ensure that shareholders' interests are well served. Bunge's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bunge's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bernardo Hees, Independent Director
Kellie Sears, Chief Officer
Tommy Jensen, CEO, Bunge Europe, Middle East & Africa
Vinita Bali, Independent Director
Frank Jimenez, General Counsel, Managing Director - Government Affairs, Secretary
J Fyrwald, Independent Director
Bernard Lauraguais, Independent Director
Brian Thomsen, Managing Director of Bunge Global Agribusiness and CEO of Bunge Product Lines
Robert Coviello, Executive Vice President and Chief Growth and Strategy Officer
Andrew Ferrier, Independent Director
Brian Zachman, President of Global Risk Management
Julio Garros, President Agribusiness Development, Operations and Milling
Raul Padilla, Managing Director of Sugar and Bioenergy and CEO of Bunge Brazil
Thomas Boehlert, CFO, Executive Vice President
Mark Zenuk, Independent Director
John McGlade, Independent Director
Mark Haden, IR Contact Officer
Deborah Borg, Executive Vice President and Chief Humar Resource and Communications Officer
Patrick Lupo, Non-Executive Chairman of the Board
Aaron Buettner, President - Bunge Loders Croklaan
L Lupo, Non-Executive Independent Chairman of the Board
Debra King, Chief Officer
David Kabbes, Executive Vice President - Corporate Affairs and Chief Legal Officer
Carol Browner, Independent Director
Michael Goettl, CEO, Bunge Asia
Erik Fyrwald, Director
Robert Wagner, Chief Risk Officer
Enrique Humanes, CEO, Bunge Argentina
Matt Simmons, Controller, Principal Accounting Officer
Soren Schroder, CEO and Director
Kenneth Simril, Independent Director
Joseph Podwika, Executive Vice President and Chief Legal Officer
Haden Mark, IR Contact Officer
Jay Winship, Independent Director
Henry Winship, Independent Director
Gordon Hardie, Managing Director of Food and Ingredients
Paul WaysRuart, Independent Director
Christos Dimopoulos, President - Global Supply Chains
Gregory Heckman, Chief Executive Officer, Director
Ruth Wisener, Vice President of Investor Relations
John Neppl, Chief Financial Officer, Executive Vice President
Michael Kobori, Independent Director
Andreas Fibig, Director
Kathleen Hyle, Independent Chairman of the Board
Pierre Mauger, Chief Development and Performance Management Officer
Ernest Bachrach, Independent Director
William Engels, Independent Director
Paul Fribourg, Independent Director
Jerry Simmons, Principal Controller
Sheila Bair, Independent Vice Chairman of the Board
Enrique Boilini, Independent Director
Todd Bastean, CEO, Bunge North America
Andrew Burke, CFO and Global Operational Excellence Officer
John CPA, Executive CFO

Bunge Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bunge a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bunge

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bunge position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bunge will appreciate offsetting losses from the drop in the long position's value.

Moving against Bunge Stock

  0.56MDLZ Mondelez International Financial Report 25th of April 2024 PairCorr
  0.55FARM Farmer Bros Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Bunge could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bunge when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bunge - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bunge Limited to buy it.
The correlation of Bunge is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bunge moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bunge Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bunge can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bunge Limited is a strong investment it is important to analyze Bunge's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bunge's future performance. For an informed investment choice regarding Bunge Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bunge Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Bunge Limited information on this page should be used as a complementary analysis to other Bunge's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Bunge Stock analysis

When running Bunge's price analysis, check to measure Bunge's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bunge is operating at the current time. Most of Bunge's value examination focuses on studying past and present price action to predict the probability of Bunge's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bunge's price. Additionally, you may evaluate how the addition of Bunge to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Bunge's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bunge. If investors know Bunge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bunge listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.898
Dividend Share
0.663
Earnings Share
12.92
Revenue Per Share
400.123
Quarterly Revenue Growth
(0.10)
The market value of Bunge Limited is measured differently than its book value, which is the value of Bunge that is recorded on the company's balance sheet. Investors also form their own opinion of Bunge's value that differs from its market value or its book value, called intrinsic value, which is Bunge's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bunge's market value can be influenced by many factors that don't directly affect Bunge's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bunge's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bunge is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bunge's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.